IL79683A - Injectable semi-solid formulations - Google Patents

Injectable semi-solid formulations

Info

Publication number
IL79683A
IL79683A IL79683A IL7968386A IL79683A IL 79683 A IL79683 A IL 79683A IL 79683 A IL79683 A IL 79683A IL 7968386 A IL7968386 A IL 7968386A IL 79683 A IL79683 A IL 79683A
Authority
IL
Israel
Prior art keywords
solid formulations
injectable semi
injectable
semi
formulations
Prior art date
Application number
IL79683A
Other languages
English (en)
Other versions
IL79683A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL79683A0 publication Critical patent/IL79683A0/xx
Publication of IL79683A publication Critical patent/IL79683A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL79683A 1985-08-19 1986-08-11 Injectable semi-solid formulations IL79683A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/766,725 US4775659A (en) 1985-08-19 1985-08-19 Injectable semi-solid formulations

Publications (2)

Publication Number Publication Date
IL79683A0 IL79683A0 (en) 1986-11-30
IL79683A true IL79683A (en) 1990-11-05

Family

ID=25077329

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79683A IL79683A (en) 1985-08-19 1986-08-11 Injectable semi-solid formulations

Country Status (12)

Country Link
US (1) US4775659A (da)
EP (1) EP0213851B1 (da)
JP (1) JPH0710781B2 (da)
AU (1) AU596806B2 (da)
CA (1) CA1269933A (da)
DE (1) DE3684386D1 (da)
DK (1) DK386986A (da)
IE (1) IE59130B1 (da)
IL (1) IL79683A (da)
NZ (1) NZ217176A (da)
PH (1) PH23476A (da)
ZA (1) ZA866025B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA866218B (en) * 1985-08-23 1988-03-30 Lilly Co Eli Injectable sustained release formulation
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5179080A (en) * 1989-08-31 1993-01-12 Clinical Homecare, Corp. Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease
CA2060223C (en) * 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
SE9202128D0 (sv) * 1992-07-09 1992-07-09 Astra Ab Precipitation of one or more active compounds in situ
US5559110A (en) * 1994-03-09 1996-09-24 The Dupont Merck Pharmaceutical Company Pharmaceutical formulations of cyclic urea type compounds
ZA9711731B (en) 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
WO2014134586A2 (en) 2013-02-28 2014-09-04 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
BR102013008990A2 (pt) * 2013-04-12 2014-12-30 Ouro Fino Participacoes E Empreendimentos S A Composições farmacêuticas compreendendo kisspeptina ou seus derivados
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2493202A (en) * 1946-06-07 1950-01-03 Merck & Co Inc Process of making a fluid oil-beeswax vehicle for the parenteral administration of drugs
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
DE3484584D1 (de) * 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
DE3340680A1 (de) * 1983-11-10 1985-05-23 Henkel Kgaa Verfahren zur erhoehung der viskositaet von oelen
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물

Also Published As

Publication number Publication date
JPS6245538A (ja) 1987-02-27
AU6119986A (en) 1987-02-26
EP0213851B1 (en) 1992-03-18
IL79683A0 (en) 1986-11-30
DK386986A (da) 1987-02-20
DK386986D0 (da) 1986-08-14
DE3684386D1 (de) 1992-04-23
NZ217176A (en) 1989-06-28
JPH0710781B2 (ja) 1995-02-08
EP0213851A2 (en) 1987-03-11
EP0213851A3 (en) 1987-09-02
ZA866025B (en) 1988-04-27
PH23476A (en) 1989-08-07
US4775659A (en) 1988-10-04
IE862212L (en) 1987-02-19
AU596806B2 (en) 1990-05-17
IE59130B1 (en) 1994-01-12
CA1269933A (en) 1990-06-05

Similar Documents

Publication Publication Date Title
IL78934A (en) Alfuzosine compositions
GB8514052D0 (en) Compositions
ZA865887B (en) Compositions
GB8509409D0 (en) Compositions
IL79683A0 (en) Injectable semi-solid formulations
PH25861A (en) Injectable sustained release formulation
EP0199235A3 (en) Phenylalkyl-2,3-dihydrobenzofurans and analogs useful as anti-inflammatory agents
GR860123B (en) Compositions
GB8504489D0 (en) Aminomethylenephosphonate compositions
GB8513550D0 (en) Compositions
GB8529409D0 (en) Aminomethylenephosphonate compositions
PH23349A (en) Anti-infective injectable formulations
GB8603048D0 (en) Lymphokine-containing compositions
GB8501400D0 (en) Compositions
GB8520289D0 (en) Compositions
IL93223A0 (en) Formulations comprising 31-azido-31-deoxythymidine
EG17458A (en) Fungicial compositions
GB8523690D0 (en) Formulations
GB8514961D0 (en) Syringes
GB8501115D0 (en) Compositions
GB8526133D0 (en) Compositions
ZA852886B (en) Compositions
GB8527406D0 (en) Compositions
GB8528980D0 (en) Compositions
GB8527416D0 (en) Compositions

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void